NCT01423370View on ClinicalTrials.gov

Safety and Efficacy of YHD1023 in Erectile Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Erectile Dysfunction
Interventions
DRUG

YHD1023

5g oral once daily

DRUG

YHD1023

5g oral twice a day

DRUG

YHD1023

10g oral once daily

DRUG

Cialis

5mg oral once daily

DRUG

Placebo

Oral

Trial Locations (1)

156-754

Yuhan Corporation, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT01423370 - Safety and Efficacy of YHD1023 in Erectile Dysfunction | Biotech Hunter | Biotech Hunter